BlueJay Syndicate
VC Fund
Baltimore, United States
BlueJay Syndicate is a VC fund in Baltimore focused on Health Care and Medical. The first angel investment network for startups with founders from the johns hopkins university.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries BlueJay Syndicate invests in
Stages BlueJay Syndicate invests in
Countries BlueJay Syndicate invests in
Investment Focus
Industry
- Health Care 4 (80%)
- Medical 3 (60%)
- mHealth 3 (60%)
- Mobile 1 (20%)
- Software 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Scene Health
|
Scene Health (formerly emocha Health) is solving the decades-old problem of medication nonadherence by leveraging the power of people, science, and technology. Scene Health's 360° model of care enhances the gold standard of medication adherence, Directly Observed Therapy. Combining personalized video coaching, education, and motivationalcontent, its bringd healthcare professionals, patients, and their families together to solve the $500B medication nonadherence problem. Scene Health's mobile app allows patients to connect with a care team of pharmacists, nurses, and health coaches through daily video check-ins, anytime and anywhere. The company makes it fun for patients to stay on top of their medications, help them address any medication challenges, and empowers them to improve their health by identifying and addressing barriers to adherence related to social determinants of health. Over 120 customers across the healthcare landscape use our medication engagement program to improve medication adherence for patients with chronic and infectious diseases. | $1M / Seed / Jun 29, 2017 | |
Quantified Care
|
Quantified Care (QC) is a dveloper of a multimedia software platform for chronic care and post-discharge management with tools for patients and clinical management teams. Patients on the platform receive personalized updates and feedback based on symptoms, medication, and vitals data collected through regular check-ins delivered through thepatient’s preferred mode of communication (mobile app, Alexa, text, phone call, or web portal). Data is captured manually or passively from connected devices and wearables. While patients receive support, clinical teams have access to analytics stratifying patients into high, medium, and low risk tiers based on QC’s clinical intelligence engine. Alerts trigger key clinical resources to take action while a secure communication layer facilitates remote patient engagement. | $1.1M / Seed / Nov 07, 2016 | |
Sonavex
|
Sonavex is committed to improving outcomes for surgical patients by using cutting-edge imaging technology to provide clinicians with visualization of critical data -- directly at the point of care. The company's technology offers a proprietary technology platform that utilizes ultrasound to detect blood clots after surgery, enabling cliniciansto measure critical intravascular flow metrics to detect post-operative clots directly at the point of care and improve outcomes. | $1M / Seed / Sep 23, 2015 | |
Emocha Health
|
Emocha enables every patient to take every dose of medication through video technology and scalable human engagement. Patients use a smartphone application to video record themselves taking their medication. Providers or emocha Adherence Coaches use a secure web portal to assess adherence and engage with patients. The platform is being used bypublic health departments, clinical trials, hospitals, health centers, and managed care organizations to radically improve medication adherence for patients with tuberculosis, opioid use disorder, hepatitis C, diabetes, and other chronic and infectious diseases. Emocha is available in more than 20 languages, works offline, and is asynchronous. It provides customizable reports to the care team and provider that provide a summary of adherence and other unique insights gleaned from daily video submissions. An NIH-funded study conducted by Johns Hopkins found that emocha helped patients achieve an average of 94 percent medication adherence. | $500K / Seed / Aug 06, 2015 | |
|
Scene Health
|
Scene Health (formerly emocha Health) is solving the decades-old problem of medication nonadherence by leveraging the power of people, science, and technology. Scene Health's 360° model of care enhances the gold standard of medication adherence, Directly Observed Therapy. Combining personalized video coaching, education, and motivationalcontent, its bringd healthcare professionals, patients, and their families together to solve the $500B medication nonadherence problem. Scene Health's mobile app allows patients to connect with a care team of pharmacists, nurses, and health coaches through daily video check-ins, anytime and anywhere. The company makes it fun for patients to stay on top of their medications, help them address any medication challenges, and empowers them to improve their health by identifying and addressing barriers to adherence related to social determinants of health. Over 120 customers across the healthcare landscape use our medication engagement program to improve medication adherence for patients with chronic and infectious diseases. | Seed / Aug 06, 2015 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does BlueJay Syndicate invest in?
BlueJay Syndicate invests primarily in Health Care, Medical and mHealth startups, most often at Seed stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did BlueJay Syndicate last invest?
The most recent investment recorded for BlueJay Syndicate closed in Jun 2017. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
